OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Subchronic exposure to mitragynine, the principal alkaloid of Mitragyna speciosa, in rats
Azadeh Sabetghadam, Surash Ramanathan, Sreenivasan Sasidharan, et al.
Journal of Ethnopharmacology (2013) Vol. 146, Iss. 3, pp. 815-823
Closed Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse
Andrew C. Kruegel, Oliver Grundmann
Neuropharmacology (2017) Vol. 134, pp. 108-120
Closed Access | Times Cited: 187

The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research
Jack E. Henningfield, Reginald V. Fant, Daniel W. Wang
Psychopharmacology (2017) Vol. 235, Iss. 2, pp. 573-589
Open Access | Times Cited: 123

A botanical, phytochemical and ethnomedicinal review of the genus Mitragyna korth: Implications for products sold as kratom
Paula N. Brown, Jensen A. Lund, Susan J. Murch
Journal of Ethnopharmacology (2017) Vol. 202, pp. 302-325
Closed Access | Times Cited: 107

Neurobiology of Kratom and its main alkaloid mitragynine
Farah Wahida Suhaimi, Nurul H.M. Yusoff, Rahimah Hassan, et al.
Brain Research Bulletin (2016) Vol. 126, pp. 29-40
Closed Access | Times Cited: 95

Hepatotoxicity Induced by “the 3Ks”: Kava, Kratom and Khat
Flaminia Pantano, Roberta Tittarelli, Giulio Mannocchi, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 4, pp. 580-580
Open Access | Times Cited: 94

Understanding Kratom Use: A Guide for Healthcare Providers
Marc T. Swogger, Kirsten E. Smith, Albert Garcia‐Romeu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 52

An insight review on the neuropharmacological effects, mechanisms of action, pharmacokinetics and toxicity of mitragynine
Nur Aisyah Khairul Annuar, Ummi Kalthum Azlan, Ahmed Mediani, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116134-116134
Open Access | Times Cited: 9

Lycopene protects against acute zearalenone-induced oxidative, endocrine, inflammatory and reproductive damages in male mice
Silvana Peterini Boeira, Vinícius Rafael Funck, Carlos Borges Filho, et al.
Chemico-Biological Interactions (2015) Vol. 230, pp. 50-57
Closed Access | Times Cited: 65

Discriminative stimulus properties of mitragynine (kratom) in rats
Norsyifa Harun, Zurina Hassan, Visweswaran Navaratnam, et al.
Psychopharmacology (2015) Vol. 232, Iss. 13, pp. 2227-2238
Closed Access | Times Cited: 65

Mitragynine Attenuates Morphine Withdrawal Effects in Rats—A Comparison With Methadone and Buprenorphine
Rahimah Hassan, Pike-See Cheah, Sreenivasan Sasidharan, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 61

Mitragyna speciosa: Clinical, Toxicological Aspects and Analysis in Biological and Non-Biological Samples
Vânia Meireles, Tiago Rosado, Mário Barroso, et al.
Medicines (2019) Vol. 6, Iss. 1, pp. 35-35
Open Access | Times Cited: 60

Kratom (Mitragyna Speciosa) Liver Injury: A Comprehensive Review
Jonathan Schimmel, Richard C. Dart
Drugs (2020) Vol. 80, Iss. 3, pp. 263-283
Closed Access | Times Cited: 53

The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review
Thiruventhan Karunakaran, Kok Zhuo Ngew, Ahmad Alif Danial Zailan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 29

Antidiabetic and antioxidant activities of Mitragyna speciosa (kratom) leaf extract in type 2 diabetic rats
Pengpeng Zhang, Wei Wei, Xiaohai Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114689-114689
Open Access | Times Cited: 16

Biochemical Benefits, Diagnosis, and Clinical Risks Evaluation of Kratom
Dimy Fluyau, Neelambika Revadigar
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 60

Evaluating the hematological and clinical-chemistry parameters of kratom (Mitragyna speciosa) users in Malaysia
Darshan Singh, Christian P. Müller, Vikneswaran Murugaiyah, et al.
Journal of Ethnopharmacology (2017) Vol. 214, pp. 197-206
Closed Access | Times Cited: 59

Pharmacologic and clinical assessment of kratom
C Michael White
American Journal of Health-System Pharmacy (2017) Vol. 75, Iss. 5, pp. 261-267
Closed Access | Times Cited: 57

Anxiolytic-like effects of mitragynine in the open-field and elevated plus-maze tests in rats
Ammar Imad Hazim, Surash Ramanathan, Suhanya Parthasarathy, et al.
The Journal of Physiological Sciences (2014) Vol. 64, Iss. 3, pp. 161-169
Open Access | Times Cited: 56

Biochemical and hematological effects of acute and sub-acute administration to ethyl acetate fraction from the stem bark Scutia buxifolia Reissek in mice
Andreia Regina Haas da Silva, Laís da Rosa Moreira, Evelyne da Silva Brum, et al.
Journal of Ethnopharmacology (2014) Vol. 153, Iss. 3, pp. 908-916
Closed Access | Times Cited: 54

Chronic mitragynine (kratom) enhances punishment resistance in natural reward seeking and impairs place learning in mice
Nurul Iman Ismail, Nanthini Jayabalan, Sharif Mahsufi Mansor, et al.
Addiction Biology (2016) Vol. 22, Iss. 4, pp. 967-976
Closed Access | Times Cited: 47

Long-Term Cognitive Effects of Kratom (Mitragyna speciosa Korth.) Use
Darshan Singh, Suresh Narayanan, Christian P. Müller, et al.
Journal of Psychoactive Drugs (2018) Vol. 51, Iss. 1, pp. 19-27
Closed Access | Times Cited: 47

The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats
Takato Hiranita, Francisco León, Jasmine S. Felix, et al.
Psychopharmacology (2019) Vol. 236, Iss. 9, pp. 2725-2734
Open Access | Times Cited: 45

Risk of death associated with kratom use compared to opioids
Jack E. Henningfield, Oliver Grundmann, Jane K. Babin, et al.
Preventive Medicine (2019) Vol. 128, pp. 105851-105851
Closed Access | Times Cited: 44

In vitro and in vivo pharmacology of kratom
Takato Hiranita, Samuel Obeng, Abhisheak Sharma, et al.
Advances in pharmacology (2022), pp. 35-76
Closed Access | Times Cited: 23

Page 1 - Next Page

Scroll to top